Literature DB >> 3197002

Two subgroups of hyperactives as adults: correlations of outcome.

B Greenfield1, L Hechtman, G Weiss.   

Abstract

This prospective study explored the association of continuing symptoms of the hyperactive syndrome with adult outcome. A fifteen year follow-up compared 61 hyperactive subjects and 41 matched controls. Outcome measures examined included continuing symptoms of the hyperactive syndrome, antisocial behaviour, substance use, and emotional difficulties. Two subgroups of the hyperactive population were identified. Those hyperactive subjects with moderate or severe continuing symptoms were characterized by significant emotional difficulties, alcohol use, and antisocial behaviour. By contrast, hyperactive subjects with none or only mild continuing symptoms at follow-up did not have other difficulties in psychosocial functioning, and were, in addition, similar to the control group in many respects. The importance of continuing symptoms in determining the adult outcome of children with a diagnosis of ADDH is discussed. Accordingly, the need for comprehensive early, and ongoing interventions is emphasized.

Entities:  

Mesh:

Year:  1988        PMID: 3197002     DOI: 10.1177/070674378803300612

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  5 in total

Review 1.  Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?

Authors:  Josephine Elia; Victoria L Vetter
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

2.  Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11.

Authors:  Mauricio Arcos-Burgos; F Xavier Castellanos; David Pineda; Francisco Lopera; Juan David Palacio; Luis Guillermo Palacio; Judith L Rapoport; Kate Berg; Joan E Bailey-Wilson; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2004-10-20       Impact factor: 11.025

Review 3.  Economic implications of attention-deficit hyperactivity disorder for healthcare systems.

Authors:  Cynthia L Leibson; Kirsten Hall Long
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 4.  Attention deficit hyperactivity disorder (ADHD) and substance use disorders.

Authors:  J J Wilson; F R Levin
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081

5.  A systematic review of global publication trends regarding long-term outcomes of ADHD.

Authors:  Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young
Journal:  Front Psychiatry       Date:  2012-01-18       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.